You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 139 No. 7, July 1979 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (93)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Beneficial Effects of Verapamil in Chronic Atrial Fibrillation

Herman O. Klein, MD; Hana Pauzner, MD; Elio Di Segni, MD; Daniel David, MD; Elieser Kaplinsky, MD

Arch Intern Med. 1979;139(7):747-749.


Abstract



Digitalis preparations frequently fail to control heart rate in many patients who have chronic atrial fibrillation, particularly during physical exertion. The effects of orally administered verapamil, 160 to 240 mg/day, on the heart rate at rest and during mild exercise were studied in 23 digitalized patients with chronic atrial fibrillation of various causes. Verapamil substantially reduced the excessive heart rate response to exercise in well-digitalized patients who had chronic atrial fibrillation.

(Arch Intern Med 139:747-749, 1979)



Author Affiliations



From the Department of Cardiology, Meir General Hospital, Kfar-Saba, Israel, and The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel (Dr Kaplinsky).


Footnotes



Accepted for publication Jan 29, 1979.

Presented at the 44th Annual Scientific Assembly of the American College of Chest Physicians, Washington, DC, Oct 31, 1978.

Reprint requests to the Department of Cardiology, Meir General Hospital, Kfar-Saba, Israel (Dr Klein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chronic atrial fibrillation: a systematic review of medical heart rate control management
Nikolaidou and Channer
Postgrad. Med. J. 2009;85:303-312.
ABSTRACT | FULL TEXT  

Rate control in permanent atrial fibrillation
Nikolaidou and Channer
BMJ 2007;335:1057-1058.
FULL TEXT  

Antiarrhythmics---from cell to clinic: past, present, and future
Hancox et al.
Heart 2000;84:14-24.
FULL TEXT  

Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens
Farshi et al.
J Am Coll Cardiol 1999;33:304-310.
ABSTRACT | FULL TEXT  

Verapamil Reduces Tachycardia-Induced Electrical Remodeling of the Atria
Tieleman et al.
Circulation 1997;95:1945-1953.
ABSTRACT | FULL TEXT  

Verapamil Therapy in the Treatment of Supraventricular Arrhythmias Following Open Heart Surgery
Waldo et al.
ANGIOLOGY 1983;34:755-763.
 

Atrial Fibrillation and Flutter: Immediate Control and Conversion With Intravenously Administered Verapamil
Tommaso et al.
Arch Intern Med 1983;143:877-881.
ABSTRACT  

Verapamil Therapy and Blood Glucose Concentration
Lang et al.
Arch Intern Med 1981;141:1724-1724.
ABSTRACT  

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects
ANTMAN et al.
ANN INTERN MED 1980;93:875-885.
ABSTRACT  

Verapamil: A New Class of Antiarrhythmic Agents With a Variety of Beneficial Cardiovascular Effects
Talano and Feerst
Arch Intern Med 1980;140:314-315.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.